Neurocrine Biosciences has announced the lease of a substantial new campus in San Diego, marking a significant expansion for the biopharmaceutical company. The move underscores Neurocrine’s commitment to growing its research and development capabilities in the region, a key hub for biotechnology innovation. The newly leased facility is expected to bolster the company’s operational capacity and accommodate its increasing workforce, reflecting robust growth amid a competitive industry landscape. This expansion not only highlights San Diego’s continued appeal as a center for life sciences but also signals Neurocrine’s strategic investment in advancing neurological and endocrine disorder treatments.
Neurocrine Expands Footprint with Major San Diego Campus Lease
Neurocrine…
—-
Author : Miles Cooper
Publish date : 2025-11-18 05:42:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8
